Advertisement
Loading...

Sakar Healthcare Limited

SAKAR.NS•NSE
Healthcare
Drug Manufacturers - Specialty & Generic
₹779.95
₹180.15(30.04%)
Indian Market opens in 15h 28m

Sakar Healthcare Limited (SAKAR.NS) Stock Overview

Explore Sakar Healthcare Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap15.3B
P/E Ratio50.80
EPS (TTM)$11.40
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$583.17
3 Months$416.20
1 Year Target$544.24

SAKAR.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sakar Healthcare Limited (SAKAR.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $544.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 50.80 and a market capitalization of 15.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
16.16%
5-Day Change
26.67%
1-Month Change
18.64%
3-Month Change
55.95%
6-Month Change
76.40%
Year-to-Date (YTD) Change
70.26%
1-Year Change
119.23%
3-Year Change
185.88%
5-Year Change
1124.43%
All-Time (Max) Change
1122.28%

Contact Information

https://www.sakarhealthcare.com
91 79 2658 4655
406, Silver Oaks Comm. Complex, Ahmedabad, NaN, 380007

Company Facts

325 Employees
IPO DateMar 16, 2017
CountryIN
Actively Trading

Frequently Asked Questions